Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in myeloma includes higher risk of prolonged transfusion dependence for both pRBC and G-CSF us, as well as higher thrombopoietin receptor agonist use.”
“Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma”
Authors: Joshua Gustine, Andrew Branagan, Diana Cirstea, Farah Rexha, Ryan Han, Andrew Yee, Marcela Maus, Matthew Frigault, Noopur Raje.
More posts featuring Robert Orlowski.
